Westyn Branch-Elliman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibiotic Prophylaxis | 10 | 2020 | 639 | 4.170 |
Why?
|
Anti-Infective Agents | 8 | 2023 | 972 | 3.370 |
Why?
|
Surgical Wound Infection | 12 | 2021 | 1540 | 2.980 |
Why?
|
Pacemaker, Artificial | 5 | 2020 | 816 | 2.240 |
Why?
|
Infection Control | 8 | 2023 | 966 | 1.800 |
Why?
|
Clostridium Infections | 4 | 2019 | 548 | 1.640 |
Why?
|
Defibrillators, Implantable | 5 | 2022 | 1440 | 1.570 |
Why?
|
Anti-Bacterial Agents | 16 | 2023 | 7181 | 1.540 |
Why?
|
Vancomycin | 6 | 2020 | 501 | 1.410 |
Why?
|
Prosthesis-Related Infections | 4 | 2020 | 538 | 1.400 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1972 | 1.380 |
Why?
|
Staphylococcal Infections | 7 | 2020 | 1400 | 1.330 |
Why?
|
Ambulatory Surgical Procedures | 4 | 2019 | 454 | 1.170 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2020 | 687 | 1.150 |
Why?
|
Veterans | 8 | 2023 | 2519 | 1.100 |
Why?
|
Veterans Health | 6 | 2024 | 216 | 1.080 |
Why?
|
Cross Infection | 6 | 2023 | 1416 | 0.990 |
Why?
|
Informed Consent | 2 | 2021 | 995 | 0.980 |
Why?
|
Communicable Diseases | 3 | 2023 | 880 | 0.940 |
Why?
|
Catheter-Related Infections | 2 | 2017 | 252 | 0.920 |
Why?
|
Hypersensitivity | 2 | 2023 | 1102 | 0.880 |
Why?
|
Virus Diseases | 2 | 2022 | 711 | 0.870 |
Why?
|
Mastitis | 2 | 2013 | 41 | 0.870 |
Why?
|
Electronic Health Records | 6 | 2021 | 4468 | 0.820 |
Why?
|
Natural Language Processing | 2 | 2023 | 1041 | 0.820 |
Why?
|
Urinary Tract Infections | 2 | 2020 | 788 | 0.810 |
Why?
|
Antiviral Agents | 6 | 2024 | 2987 | 0.810 |
Why?
|
Therapeutic Human Experimentation | 1 | 2021 | 43 | 0.800 |
Why?
|
Pyuria | 1 | 2020 | 30 | 0.750 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2015 | 274 | 0.750 |
Why?
|
Hospitals, Veterans | 8 | 2022 | 404 | 0.730 |
Why?
|
Norovirus | 1 | 2020 | 35 | 0.720 |
Why?
|
Quarantine | 1 | 2022 | 170 | 0.710 |
Why?
|
Civil Defense | 1 | 2021 | 109 | 0.680 |
Why?
|
Guideline Adherence | 3 | 2019 | 2266 | 0.670 |
Why?
|
Patient Identification Systems | 1 | 2019 | 79 | 0.670 |
Why?
|
Abscess | 2 | 2013 | 607 | 0.660 |
Why?
|
Bacterial Infections | 2 | 2017 | 1401 | 0.660 |
Why?
|
Algorithms | 7 | 2021 | 13881 | 0.630 |
Why?
|
Gastroenteritis | 1 | 2020 | 245 | 0.620 |
Why?
|
Catheters, Indwelling | 2 | 2017 | 426 | 0.620 |
Why?
|
Pandemics | 7 | 2023 | 8388 | 0.590 |
Why?
|
Population Surveillance | 2 | 2020 | 2616 | 0.580 |
Why?
|
Sterilization | 1 | 2017 | 133 | 0.560 |
Why?
|
Documentation | 2 | 2020 | 871 | 0.540 |
Why?
|
Humans | 88 | 2024 | 744343 | 0.540 |
Why?
|
beta-Lactams | 1 | 2017 | 160 | 0.530 |
Why?
|
Outpatients | 3 | 2023 | 1486 | 0.520 |
Why?
|
Data Mining | 1 | 2020 | 537 | 0.520 |
Why?
|
Laboratories, Hospital | 1 | 2017 | 194 | 0.520 |
Why?
|
Quality Assurance, Health Care | 2 | 2023 | 2212 | 0.510 |
Why?
|
Staphylococcus aureus | 3 | 2019 | 1451 | 0.510 |
Why?
|
United States Department of Veterans Affairs | 5 | 2020 | 875 | 0.500 |
Why?
|
Intensive Care Units | 4 | 2018 | 3679 | 0.490 |
Why?
|
Bacteremia | 1 | 2021 | 962 | 0.490 |
Why?
|
Neutropenia | 1 | 2019 | 895 | 0.490 |
Why?
|
Immunocompromised Host | 1 | 2019 | 847 | 0.490 |
Why?
|
Drug Hypersensitivity | 1 | 2023 | 884 | 0.480 |
Why?
|
Housekeeping, Hospital | 1 | 2014 | 17 | 0.480 |
Why?
|
Ligation | 1 | 2015 | 453 | 0.480 |
Why?
|
Disease Outbreaks | 4 | 2021 | 1772 | 0.480 |
Why?
|
Retrospective Studies | 28 | 2023 | 77449 | 0.470 |
Why?
|
Environmental Microbiology | 1 | 2014 | 46 | 0.470 |
Why?
|
Office Visits | 1 | 2018 | 598 | 0.470 |
Why?
|
Patients' Rooms | 1 | 2014 | 63 | 0.470 |
Why?
|
Data Collection | 2 | 2020 | 3341 | 0.460 |
Why?
|
Education, Professional | 1 | 2014 | 54 | 0.460 |
Why?
|
Computer Systems | 1 | 2015 | 483 | 0.460 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5391 | 0.460 |
Why?
|
Schools | 4 | 2022 | 1433 | 0.450 |
Why?
|
Anti-Inflammatory Agents | 2 | 2023 | 1790 | 0.440 |
Why?
|
Esophageal and Gastric Varices | 1 | 2015 | 207 | 0.440 |
Why?
|
Hospital Costs | 2 | 2017 | 985 | 0.420 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2015 | 253 | 0.410 |
Why?
|
Influenza Vaccines | 1 | 2019 | 738 | 0.410 |
Why?
|
Hysterectomy | 1 | 2018 | 927 | 0.410 |
Why?
|
Disinfection | 1 | 2014 | 191 | 0.410 |
Why?
|
Luminescent Measurements | 1 | 2014 | 405 | 0.400 |
Why?
|
Drug Contamination | 1 | 2012 | 147 | 0.380 |
Why?
|
Vaccination | 6 | 2023 | 3278 | 0.380 |
Why?
|
Patient Admission | 1 | 2018 | 1380 | 0.380 |
Why?
|
Program Development | 1 | 2017 | 1316 | 0.370 |
Why?
|
Disease Transmission, Infectious | 1 | 2015 | 547 | 0.350 |
Why?
|
Postpartum Period | 2 | 2013 | 1086 | 0.350 |
Why?
|
Aged | 26 | 2024 | 163280 | 0.350 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 346 | 0.350 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 1876 | 0.340 |
Why?
|
Feedback | 2 | 2023 | 795 | 0.330 |
Why?
|
Secondary Prevention | 1 | 2015 | 1530 | 0.320 |
Why?
|
United States | 19 | 2022 | 69872 | 0.320 |
Why?
|
Influenza, Human | 1 | 2019 | 1479 | 0.310 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2015 | 1130 | 0.300 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 2025 | 0.300 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 961 | 0.300 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2569 | 0.300 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2208 | 0.300 |
Why?
|
Workload | 1 | 2013 | 850 | 0.290 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2021 | 567 | 0.260 |
Why?
|
Cohort Studies | 10 | 2023 | 40561 | 0.250 |
Why?
|
Biomedical Research | 1 | 2021 | 3309 | 0.250 |
Why?
|
Endoscopy | 1 | 2015 | 1785 | 0.250 |
Why?
|
Research Design | 1 | 2021 | 5987 | 0.250 |
Why?
|
Quality Improvement | 5 | 2020 | 3749 | 0.240 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3523 | 0.240 |
Why?
|
Male | 28 | 2024 | 350118 | 0.230 |
Why?
|
Middle Aged | 22 | 2022 | 213383 | 0.230 |
Why?
|
Aged, 80 and over | 11 | 2022 | 57776 | 0.210 |
Why?
|
Female | 27 | 2024 | 380194 | 0.210 |
Why?
|
Sisomicin | 1 | 2021 | 6 | 0.210 |
Why?
|
Drug Users | 1 | 2023 | 134 | 0.210 |
Why?
|
Klebsiella | 1 | 2021 | 48 | 0.200 |
Why?
|
Hepatitis C | 1 | 2012 | 1591 | 0.200 |
Why?
|
Incidence | 4 | 2022 | 20947 | 0.190 |
Why?
|
Mass Vaccination | 1 | 2022 | 105 | 0.190 |
Why?
|
Caliciviridae Infections | 1 | 2020 | 29 | 0.180 |
Why?
|
Risk Factors | 10 | 2022 | 72290 | 0.180 |
Why?
|
Academic Medical Centers | 3 | 2020 | 2759 | 0.180 |
Why?
|
Paraproteinemias | 1 | 2022 | 246 | 0.180 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2023 | 277 | 0.180 |
Why?
|
Inappropriate Prescribing | 1 | 2022 | 202 | 0.170 |
Why?
|
Policy | 1 | 2023 | 508 | 0.170 |
Why?
|
Cefazolin | 1 | 2019 | 96 | 0.170 |
Why?
|
Oseltamivir | 1 | 2019 | 75 | 0.170 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 257 | 0.170 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.170 |
Why?
|
Radiology, Interventional | 1 | 2023 | 460 | 0.170 |
Why?
|
Dexamethasone | 2 | 2023 | 1951 | 0.170 |
Why?
|
Substance Abuse, Intravenous | 1 | 2023 | 525 | 0.170 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7659 | 0.170 |
Why?
|
Public Policy | 1 | 2023 | 572 | 0.170 |
Why?
|
Soaps | 1 | 2018 | 28 | 0.160 |
Why?
|
Bacteriuria | 1 | 2019 | 102 | 0.160 |
Why?
|
Treatment Outcome | 8 | 2023 | 63114 | 0.160 |
Why?
|
Death | 1 | 2023 | 678 | 0.160 |
Why?
|
Urinalysis | 1 | 2020 | 369 | 0.160 |
Why?
|
Daptomycin | 1 | 2018 | 73 | 0.160 |
Why?
|
Arthritis | 1 | 2023 | 659 | 0.150 |
Why?
|
Goals | 1 | 2023 | 706 | 0.150 |
Why?
|
Validation Studies as Topic | 1 | 2017 | 159 | 0.150 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 685 | 0.150 |
Why?
|
Boston | 4 | 2020 | 9313 | 0.150 |
Why?
|
Arthroplasty | 1 | 2019 | 305 | 0.150 |
Why?
|
Adult | 14 | 2024 | 214055 | 0.140 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5319 | 0.140 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2019 | 341 | 0.140 |
Why?
|
Electrophysiology | 1 | 2019 | 1308 | 0.140 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.140 |
Why?
|
Critical Pathways | 1 | 2020 | 476 | 0.140 |
Why?
|
Candida | 1 | 2017 | 172 | 0.140 |
Why?
|
Microbiological Techniques | 1 | 2017 | 102 | 0.140 |
Why?
|
Equipment Contamination | 1 | 2017 | 185 | 0.130 |
Why?
|
Psoriasis | 1 | 2023 | 898 | 0.130 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15165 | 0.130 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 613 | 0.130 |
Why?
|
Probability | 1 | 2020 | 2505 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.120 |
Why?
|
Surgical Instruments | 1 | 2017 | 395 | 0.120 |
Why?
|
Candidiasis | 1 | 2017 | 366 | 0.120 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2017 | 493 | 0.120 |
Why?
|
Hospitalization | 3 | 2022 | 10262 | 0.120 |
Why?
|
Health Personnel | 2 | 2019 | 3218 | 0.120 |
Why?
|
Hospitals | 3 | 2023 | 3952 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2024 | 21746 | 0.110 |
Why?
|
Carrier State | 1 | 2017 | 518 | 0.110 |
Why?
|
Communicable Diseases, Emerging | 1 | 2015 | 157 | 0.110 |
Why?
|
Decision Trees | 1 | 2015 | 506 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1978 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1842 | 0.110 |
Why?
|
Motivation | 1 | 2023 | 1971 | 0.110 |
Why?
|
Sentinel Surveillance | 1 | 2014 | 281 | 0.110 |
Why?
|
Diarrhea | 1 | 2019 | 1348 | 0.110 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1832 | 0.100 |
Why?
|
Drug Combinations | 1 | 2017 | 1959 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3176 | 0.100 |
Why?
|
Markov Chains | 1 | 2015 | 969 | 0.100 |
Why?
|
Students | 1 | 2021 | 1654 | 0.100 |
Why?
|
Drug Utilization | 1 | 2018 | 1183 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 783 | 0.100 |
Why?
|
Quality Control | 1 | 2014 | 841 | 0.100 |
Why?
|
Device Removal | 1 | 2016 | 656 | 0.100 |
Why?
|
Models, Economic | 1 | 2015 | 713 | 0.100 |
Why?
|
Health Policy | 1 | 2023 | 2661 | 0.100 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1288 | 0.090 |
Why?
|
Triage | 1 | 2017 | 976 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12245 | 0.090 |
Why?
|
Operating Rooms | 1 | 2017 | 817 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1637 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
Loneliness | 2 | 2022 | 185 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2023 | 2538 | 0.090 |
Why?
|
New York City | 1 | 2012 | 710 | 0.090 |
Why?
|
Plasma Cells | 2 | 2023 | 591 | 0.090 |
Why?
|
Aspirin | 1 | 2021 | 3282 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2015 | 1462 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2425 | 0.080 |
Why?
|
Occupational Health | 1 | 2015 | 809 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1643 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3068 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2971 | 0.080 |
Why?
|
Health Services | 1 | 2013 | 758 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3712 | 0.080 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2716 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4258 | 0.070 |
Why?
|
Pilot Projects | 2 | 2023 | 8324 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13408 | 0.070 |
Why?
|
Intubation, Intratracheal | 1 | 2015 | 1364 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2488 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2022 | 13033 | 0.070 |
Why?
|
Time Factors | 3 | 2018 | 40075 | 0.070 |
Why?
|
Ambulatory Care Facilities | 1 | 2012 | 933 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2013 | 2453 | 0.070 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 12720 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7729 | 0.060 |
Why?
|
Preoperative Period | 2 | 2019 | 549 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12354 | 0.060 |
Why?
|
Cost of Illness | 1 | 2013 | 1859 | 0.060 |
Why?
|
Recurrence | 1 | 2015 | 8340 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8642 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2018 | 15295 | 0.060 |
Why?
|
Prospective Studies | 3 | 2022 | 53288 | 0.060 |
Why?
|
Harm Reduction | 1 | 2023 | 129 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3674 | 0.050 |
Why?
|
Breast | 1 | 2011 | 1969 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5442 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15076 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6309 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14722 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.050 |
Why?
|
Mass Screening | 2 | 2019 | 5255 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9849 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2015 | 4234 | 0.050 |
Why?
|
Naltrexone | 1 | 2023 | 307 | 0.050 |
Why?
|
Pregnancy | 2 | 2013 | 29144 | 0.050 |
Why?
|
Vascular Patency | 1 | 2023 | 886 | 0.050 |
Why?
|
Young Adult | 4 | 2021 | 56430 | 0.050 |
Why?
|
Health Care Costs | 1 | 2013 | 3209 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2023 | 549 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 2019 | 198 | 0.040 |
Why?
|
Infusions, Parenteral | 1 | 2018 | 419 | 0.040 |
Why?
|
Anxiety | 2 | 2022 | 4297 | 0.040 |
Why?
|
Child | 2 | 2022 | 77709 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4687 | 0.040 |
Why?
|
Adolescent | 3 | 2021 | 85781 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25043 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1531 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1071 | 0.030 |
Why?
|
Hepacivirus | 1 | 2002 | 1379 | 0.030 |
Why?
|
Geriatrics | 1 | 2018 | 396 | 0.030 |
Why?
|
Teaching | 1 | 2021 | 1174 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2023 | 1786 | 0.030 |
Why?
|
RNA, Viral | 1 | 2002 | 2902 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21683 | 0.030 |
Why?
|
Depression | 2 | 2022 | 7766 | 0.030 |
Why?
|
Educational Measurement | 1 | 2018 | 1210 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2011 | 25625 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2518 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4189 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9687 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1439 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12026 | 0.020 |
Why?
|
Nose | 1 | 2012 | 509 | 0.020 |
Why?
|
Software | 1 | 2002 | 4443 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3493 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4245 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15226 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3605 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6171 | 0.010 |
Why?
|
Reading Frames | 1 | 2002 | 18 | 0.010 |
Why?
|
Viral Core Proteins | 1 | 2002 | 162 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29063 | 0.010 |
Why?
|
Consensus Sequence | 1 | 2002 | 377 | 0.010 |
Why?
|
Viral Nonstructural Proteins | 1 | 2002 | 241 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2002 | 936 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41006 | 0.010 |
Why?
|
Genome, Viral | 1 | 2002 | 667 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2002 | 2256 | 0.010 |
Why?
|
Mutation | 1 | 2002 | 29786 | 0.010 |
Why?
|
Point Mutation | 1 | 2002 | 1623 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3846 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13815 | 0.010 |
Why?
|
Computational Biology | 1 | 2002 | 3521 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 18111 | 0.010 |
Why?
|
Genotype | 1 | 2002 | 12951 | 0.000 |
Why?
|